Work

Characterization of Survival Outcomes and Clinical and Molecular Modulators in Adult Patients with Core-Binding Factor Acute Myeloid Leukemia (CBF-AML) Treated with Hidac Consolidation: An Alliance Legacy Study

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-167210

Authors: Jonathan Hyak, Deedra Nicolet, Jessica Kohlschmidt, Kellie J. Archer, James S. Blachly, Karilyn T. Larkin, Bayard L. Powell, Jonathan E. Kolitz, Maria R. Baer, William G. Blum, Geoffrey L. Uy, Wendy Stock, Richard M. Stone, John C. Byrd, Krzysztof Mrózek, Ann-Kathrin Eisfeld, Alice S. Mims

Institutions: The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Wake Forest Baptist Comprehensive Cancer Center, Northwell Health, North Shore University Hospital, Long Island Jewish Medical Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Winship Cancer Institute, Washington University in St. Louis, University of Chicago, Dana-Farber Cancer Institute, University of Cincinnati

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310107584

FWCI:

Cites:

Cited by:

Related to: 10